1
Por Kitamoto, Tetsuyuki., International Symposium of Prion Diseases for Food and Drug Safety
Publicado em 2005
“... (vCJD) in the United Kingdom. In 2004, the International symposium of prion diseases for food and drug...”Publicado em 2005
Obter o texto integral
Livro
2
Por Ritchwood, Tiarney D., DeCoster, Jamie, Metzger, Isha, Bolland, John M., Danielson, Carla K.
Publicado no Addict Behav (2016)
“... the consideration of type of SU, and particular combinations of substances, on RSBs in intervention development....”Publicado no Addict Behav (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Souza, Maurício Palmeira Chaves de, Sábio, Rafael Miguel, Ribeiro, Tais de Cassia, Santos, Aline Martins dos, Meneguin, Andréia Bagliotti, Chorilli, Marlus
Publicado no Int J Biol Macromol (2020)
“...The development of gastroretentive systems have been growing lately due to the high demand...”Publicado no Int J Biol Macromol (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“...Twenty antiviral drugs, that is about half of those that are currently approved, are formally...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por De Smedt, Eva, Lui, Hui, Maes, Ken, De Veirman, Kim, Menu, Eline, Vanderkerken, Karin, De Bruyne, Elke
Publicado no Front Oncol (2018)
“... in treatment modalities, MM remains most often incurable due to the development of drug resistance to all...”Publicado no Front Oncol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Ursini, Francesco, Russo, Emilio, Pellino, Gianluca, D’Angelo, Salvatore, Chiaravalloti, Agostino, De Sarro, Giovambattista, Manfredini, Roberto, De Giorgio, Roberto
Publicado no Front Immunol (2018)
“... ago, metformin represents a worldwide milestone in treatment of patients with type 2 diabetes (T2D...”Publicado no Front Immunol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Mariana Rodrigues da Rocha, Sinderlândia Domingas dos Santos, Karine Rafaela de Moura, Lesliane de Sousa Carvalho, Ionara Holanda de Moura, Ana Roberta Vilarouca da Silva
Publicado em 2019-02-01
“... of patients with Type 2 Diabetes Mellitus. Method: Quantitative cross-sectional study developed in five...”Publicado em 2019-02-01
Obter o texto integral
Artigo
8
Por Lacerda, Ariane F., Pelegrini, Patrícia B., de Oliveira, Daiane M., Vasconcelos, Érico A. R., Grossi-de-Sá, Maria F.
Publicado no Front Microbiol (2016)
“..., as there is not yet a cure for them and the drugs used are inefficient against the pathogenic parasites. During...”Publicado no Front Microbiol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Halicki, Priscila C. B., Ferreira, Laís A., De Moura, Kelly C. G., Carneiro, Paula F., Del Rio, Karina P., Carvalho, Tatiane dos S. C., Pinto, Maria do C. F. R., da Silva, Pedro E. A., Ramos, Daniela F.
Publicado no Front Microbiol (2018)
“... of resistant Mycobacterium tuberculosis strains. These barriers reinforcing the need for development of new...”Publicado no Front Microbiol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Maíra Rocha Machado, Mariana Celano de Souza Amaral, Matheus de Barros, Ana Clara Klink de Melo
Publicado em 2019-06-01
Assuntos:
“...drug trafficking...”Publicado em 2019-06-01
Obter o texto integral
Artigo
11
Por De Ridder, Thomas, Ruppin, Mick, Wheeless, Meagan, Williams, Stephanie, Reddell, Paul
Publicado no Front Vet Sci (2020)
“... for intratumoural treatment of non-metastatic, non-resectable canine mast cell tumors. The drug has a “tumor...”Publicado no Front Vet Sci (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Dienstmann, Rodrigo, De Dosso, Sara, Felip, Enriqueta, Tabernero, Josep
Publicado no Mol Oncol (2011)
“... also improved the efficacy outcomes in KRAS wild‐type colorectal cancer. Nevertheless, a significant...”Publicado no Mol Oncol (2011)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Imbrici, Paola, Liantonio, Antonella, Camerino, Giulia M., De Bellis, Michela, Camerino, Claudia, Mele, Antonietta, Giustino, Arcangela, Pierno, Sabata, De Luca, Annamaria, Tricarico, Domenico, Desaphy, Jean-Francois, Conte, Diana
Publicado no Front Pharmacol (2016)
“... to drugs: this opens the way to a pharmacogenetics strategy, allowing the development of a personalized...”Publicado no Front Pharmacol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
“.... The bacterial type III secretion system (T3SS) is an attractive target for developing antibacterials...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Mittermayer, Friedrich, Caveney, Erica, Oliveira, Claudia De, Gourgiotis, Loukas, Puri, Mala, Tai, Li-Jung, J, Rick Turner
Publicado no Curr Diabetes Rev (2015)
“... available, and many new drugs are under clinical development. These include compounds with known mechanisms...”Publicado no Curr Diabetes Rev (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Jardim, Denis L., de Melo Gagliato, Débora, Giles, Francis J., Kurzrock, Razelle
Publicado no Clin Cancer Res (2017)
“... drug development/approval models on the accuracy of safety and efficacy assessments by searching the US...”Publicado no Clin Cancer Res (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Patricio, B. F. de Carvalho, Albernaz, M. de Souza, Patricio, B. F. de Carvalho, Albernaz, M. de Souza, Santos-Oliveira, R.
Publicado em 2013
“... research directed at developing nanoradiopharmaceuticals based on three different types...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Mittermayer, Friedrich, Caveney, Erica, De Oliveira, Claudia, Fleming, G. Alexander, Gourgiotis, Loukas, Puri, Mala, Tai, Li-Jung, Turner, J. Rick
Publicado no Curr Diabetes Rev (2017)
“... for the treatment of T1D. Drugs already in use for type 2 diabetes and many new drugs are under clinical development...”Publicado no Curr Diabetes Rev (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
“.... The critical nature of these proteins in cell cycling raises hope that targeting them may result in selective...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Sun, Ya-Zhou, Zhang, De-Hong, Cai, Shu-Bin, Ming, Zhong, Li, Jian-Qiang, Chen, Xing
Publicado no Front Cell Infect Microbiol (2018)
“... of microbes in the human body or the complex mechanisms of interaction between them and drugs, which...”Publicado no Front Cell Infect Microbiol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo